Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE S W DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE S W DEXTROSE 5 IN PLASTIC CONTAINER.
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER vs ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Electrolyte and fluid replacement; dextrose provides caloric support.
Isolyte S with Dextrose 5% is an intravenous solution providing electrolytes and calories. Dextrose supplies glucose for cellular energy metabolism, while electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain acid-base balance and osmotic pressure. Acetate and gluconate are metabolized to bicarbonate, providing alkalinizing effect.
Intravenous infusion; rate based on fluid and electrolyte requirements, typically 1-2 mL/kg/hour for maintenance in adults.
Intravenous infusion; dose determined by fluid and electrolyte requirements. Typical adult maintenance: 100-200 mL/h (2.4-4.8 L/day) depending on clinical status.
None Documented
None Documented
Not applicable; components are endogenous substances. Dextrose has a plasma half-life of approximately 1.5-2.5 hours in normal glucose metabolism; electrolytes have half-lives dependent on renal function (e.g., sodium half-life ~1-2 days).
Not applicable for the combination; individual components: dextrose has an elimination half-life of 15-20 minutes, electrolytes are not eliminated as a drug.
Renal excretion of water and electrolytes; dextrose is metabolized to CO2 and water. >90% of water and electrolytes are excreted renally; dextrose is fully metabolized.
Renal excretion of electrolytes and water; dextrose is metabolized to CO2 and water, with <0.5% excreted unchanged in urine.
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution